Company Filing History:
Years Active: 2019-2024
Title: Matthias R Meyer: Innovator in Molecular Biology and Pharmacology
Introduction
Matthias R Meyer is a notable inventor based in Stallikon, Switzerland. He has made significant contributions to the fields of molecular biology and pharmacology, particularly in the treatment of obesity, diabetes, and related diseases. With a total of 4 patents to his name, his work continues to impact the scientific community.
Latest Patents
One of Matthias R Meyer's latest patents focuses on a method for treating obesity, diabetes, cardiovascular, and kidney diseases by regulating GPR30/GPER activity. This invention provides methods for using compounds that modulate the effects of GPR30/GPER, particularly agonists for treating obesity and diabetes. Additionally, it addresses disease states resulting from excessive formation of reactive oxygen species, utilizing antagonists to counteract these effects. The compounds developed may function as both agonists and antagonists of the disclosed estrogen receptor, while also modulating the expression and upregulation of NOX and NOX-associated reactive oxygen species (ROS).
Career Highlights
Throughout his career, Matthias R Meyer has worked with various organizations, including Stc.unm and Unm Rainforest Innovations. His innovative approaches and research have positioned him as a key figure in his field.
Collaborations
Matthias R Meyer has collaborated with notable individuals such as Eric R Prossnitz and Matthias Barton. These partnerships have further enhanced his research and contributions to the scientific community.
Conclusion
Matthias R Meyer is a distinguished inventor whose work in molecular biology and pharmacology has led to significant advancements in treating critical health conditions. His innovative patents and collaborations continue to shape the future of medical research and treatment.